Reneo Pharmaceuticals

Investment area
Venture Investments
Region
North America
Date of investment
December 2020

Reneo is a clinical-stage pharmaceutical company focused on the development of therapies for patients with rare genetic mitochondrial diseases with significant unmet medical needs.

Reneo Pharmaceuticals

Investment area
Venture Investments
Region
North America
Date of investment
December 2020

Reneo is a clinical-stage pharmaceutical company focused on the development of therapies for patients with rare genetic mitochondrial diseases with significant unmet medical needs.

Reneo Pharmaceuticals

Investment area
Venture Investments
Region
North America
Date of investment
December 2020

Reneo is a clinical-stage pharmaceutical company focused on the development of therapies for patients with rare genetic mitochondrial diseases with significant unmet medical needs.